trimetazidine has been researched along with Cirrhosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| El-Khodary, NM; El-Tayaar, AA; El-Touny, EM; Ghoneim, AI | 1 |
| Chen, X; Dong, T; Du, L; Lin, Z; Xia, X; Zhou, H | 1 |
| Fedorchenko, MV; Petrovskyi, RV; Seredyuk, NM | 1 |
| Bai, X; He, X; Jiang, P; Li, W; Sun, Y; Wang, X; Zhang, J; Zhang, Y | 1 |
| Atilgan, D; Erdemir, F; Erkorkmaz, U; Markoc, F; Parlaktas, BS; Saylan, O; Uluocak, N | 1 |
| Ding, WY; Li, Y; Tang, MX; Wang, F; Wang, ZH; Zhang, L; Zhang, W; Zhang, Y; Zhong, M | 1 |
| Gai, Y; Gao, W; Li, Z; Liu, F; Liu, X; Xu, M; Zhang, Y | 1 |
| Doucet, C; Dutheil, D; Eugène, M; Faure, JP; Favreau, F; Goujon, JM; Hauet, T; Mauco, G; Petit, I; Tillement, JP; Vandewalle, A; Zhang, K | 1 |
| Karaoglu, AO; Ozutemiz, O; Tuncyurek, M; Yenisey, C; Yukselen, V | 1 |
| Cau, J; Favreau, F; Goujon, JM; Hauet, T; Lerman, LO; Tillement, JP | 1 |
| Baumert, H; Carretier, M; Goujon, JM; Hauet, T; Vandewalle, A | 1 |
1 trial(s) available for trimetazidine and Cirrhosis
| Article | Year |
|---|---|
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients.
Topics: Angina Pectoris; Cardiomyopathies; Fibrosis; Humans; Inflammation; Myocardial Ischemia; Trimetazidine; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2023 |
10 other study(ies) available for trimetazidine and Cirrhosis
| Article | Year |
|---|---|
Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition.
Topics: Animals; Cardiomyopathies; Epithelial-Mesenchymal Transition; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; NF-kappa B; Rats; Rats, Sprague-Dawley; Stroke Volume; Transforming Growth Factor beta; Trimetazidine; Ventricular Function, Left | 2022 |
Influence of trimetazidine and levocarnitine on clinical course, structural and functional changes and myocardial fibrosis in patients with myocardial infarction.
Topics: Fibrosis; Humans; Myocardial Infarction; Treatment Outcome; Trimetazidine | 2019 |
Protective effect of trimetazidine in radiation-induced cardiac fibrosis in mice.
Topics: Animals; Connective Tissue Growth Factor; Fibrosis; Gene Expression Regulation; Male; Mice, Inbred C57BL; Myocardium; Radiation-Protective Agents; RNA, Messenger; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Trimetazidine | 2020 |
The effects of trimetazidine and sildenafil on bilateral cavernosal nerve injury induced oxidative damage and cavernosal fibrosis in rats.
Topics: Animals; Fibrosis; Male; Malondialdehyde; Oxidative Stress; Penis; Piperazines; Purines; Random Allocation; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Superoxide Dismutase; Trauma, Nervous System; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2014 |
Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy.
Topics: Adenylate Kinase; Animals; Apoptosis; Autophagy; Blood Glucose; Catheterization; Collagen; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Disease Models, Animal; Fibrosis; Glucose Intolerance; Insulin; Male; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction; Trimetazidine; Ventricular Dysfunction, Left | 2016 |
Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Fibrosis; Hypertension; Male; Malondialdehyde; Myocardium; NADPH Oxidases; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Trimetazidine; Vasodilator Agents | 2010 |
Protective roles of polyethylene glycol and trimetazidine against cold ischemia and reperfusion injuries of pig kidney graft.
Topics: Animals; CD4-Positive T-Lymphocytes; Cold Temperature; Fibrosis; Glomerular Filtration Rate; Graft Survival; Immunohistochemistry; Kidney; Kidney Transplantation; Organ Preservation; Organ Preservation Solutions; Polyethylene Glycols; Potassium; Reperfusion Injury; Solvents; Swine; T-Lymphocytes; Time Factors; Trimetazidine | 2004 |
Trimetazidine reduces the degree of fibrosis in alkali burns of the esophagus.
Topics: Animals; Burns, Chemical; Caustics; Drug Evaluation, Preclinical; Esophageal Stenosis; Esophagus; Fibrosis; Hydroxyproline; Injections, Intraperitoneal; Random Allocation; Rats; Rats, Wistar; Sodium Hydroxide; Trimetazidine | 2005 |
Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: a dose effect study.
Topics: Animals; Apoptosis; Blotting, Western; Dose-Response Relationship, Drug; Fibrosis; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kidney; Nephrectomy; Renal Circulation; Reperfusion Injury; Swine; Tissue Survival; Trimetazidine; Vasodilator Agents; Vimentin; Warm Ischemia | 2008 |
Influence of cold-storage conditions on renal function of autotransplanted large pig kidneys.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cryopreservation; Fibrosis; Glomerular Filtration Rate; Graft Survival; Hypertonic Solutions; Ischemia; Kidney; Kidney Transplantation; Macrophages; Monocytes; Nephrectomy; Organ Preservation Solutions; Sodium; Swine; Transplantation, Autologous; Trimetazidine; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2000 |